The first GLP- 1 medication (Exenatide) was approved in 2005 by the U.S
license suspended, Canadian Broadcasting Corporation (2023) Personal importation, Food and Drug Administration (2024) Save on Ozempic (semaglutide) injection, Novo Nordisk FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food & Drug Administration (2025) Internet pharmacy warning letters, Food & Drug Administration (2025) How to buy medicines safely from an online pharmacy, Food & Drug Administration (2025) Supply of Ozempic and other GLP-1 receptor agonists: Notice, Government of Canada (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food & Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
Unlike single-target medications, it simultaneously stimulates GLP-1, GIP, and glucagon receptors, creating a synergistic effect on metabolic rate and adipose tissue reduction
Avoid artificial sweeteners Sugar substitutes are often present in foods promoted for weight loss